$2.11
Scynexis is a drug manufacturers - specialty & generic business based in the US. Scynexis shares (SCYX) are listed on the NASDAQ and all prices are listed in US Dollars. Scynexis employs 29 staff and has a trailing 12-month revenue of around $140.4 million.
Our top picks for where to buy Scynexis stock
How to buy Scynexis stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – SCYX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Scynexis stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Scynexis stock price (NASDAQ: SCYX)
Use our graph to track the performance of SCYX stocks over time.Scynexis shares at a glance
Latest market close | $2.09 |
---|---|
52-week range | $1.35 - $3.87 |
50-day moving average | $2.16 |
200-day moving average | $1.85 |
Wall St. target price | $6.88 |
PE ratio | 1.0095 |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $2.11 |
Is it a good time to buy Scynexis stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Scynexis price performance over time
Historical closes compared with the close of $2.085 from 2024-07-25
1 week (2024-07-19) | -2.11% |
---|---|
1 month (2024-06-27) | 2.71% |
3 months (2024-04-26) | 35.39% |
6 months (2024-01-26) | 12.10% |
1 year (2023-07-27) | -25.80% |
---|---|
2 years (2022-07-27) | -5.23% |
3 years (2021-07-27) | 6.9 |
5 years (2019-07-26) | 11.55 |
Is Scynexis stock undervalued or overvalued?
Valuing Scynexis stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Scynexis's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Scynexis's P/E ratio
Scynexis's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 1x. In other words, Scynexis shares trade at around 1x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Scynexis's EBITDA
Scynexis's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $74.4 million.
The EBITDA is a measure of a Scynexis's overall financial performance and is widely used to measure a its profitability.
Scynexis financials
Revenue TTM | $140.4 million |
---|---|
Gross profit TTM | $12.9 million |
Return on assets TTM | 48.96% |
Return on equity TTM | 45.86% |
Profit margin | 72.18% |
Book value | $1.96 |
Market Capitalization | $80.5 million |
TTM: trailing 12 months
Scynexis share dividends
We're not expecting Scynexis to pay a dividend over the next 12 months.
Have Scynexis's shares ever split?
Scynexis's shares were split on a 1:10 basis on 16 July 2020. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Scynexis shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Scynexis shares which in turn could have impacted Scynexis's share price.
Scynexis share price volatility
Over the last 12 months, Scynexis's shares have ranged in value from as little as $1.35 up to $3.87. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Scynexis's is 1.515. This would suggest that Scynexis's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Scynexis overview
SCYNEXIS, Inc. , a biotechnology company, develops medicines to overcome and prevent difficult-to-treat and drug-resistant infections in the United States. It offers BREXAFEMME for the treatment of patients with vulvovaginal candidiasis (VVC) and recurrent VVC. The company's lead product candidate is Ibrexafungerp, an intravenous drug for the treatment of invasive candidiasis and/or candidemia, refractory invasive fungal infections, invasive aspergillosis, VVC, and recurrent VVC. It also develops SCY-247 to treat systemic fungal diseases. The company has licensing and collaboration agreements with GlaxoSmithKline Intellectual Property (No. 3) Limited, Merck Sharp & Dohme Corp.
Frequently asked questions
What percentage of Scynexis is owned by insiders or institutions?Currently 1.176% of Scynexis shares are held by insiders and 43.723% by institutions. How many people work for Scynexis?
Latest data suggests 29 work at Scynexis. When does the fiscal year end for Scynexis?
Scynexis's fiscal year ends in December. Where is Scynexis based?
Scynexis's address is: 1 Evertrust Plaza, Jersey City, NJ, United States, 07302-6548 What is Scynexis's ISIN number?
Scynexis's international securities identification number is: US8112922005 What is Scynexis's CUSIP number?
Scynexis's Committee on Uniform Securities Identification Procedures number is: 811292101
More guides on Finder
-
Opto review 2024: $0 commission, fractional theme investing
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
Put options explained
Learn the basics of put options: what they are, how they work and a few examples.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
11 apps like Webull you need to consider
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question